The brand said it is on track to bring the “world’s first circulating tumor DNA-based early detection test for ovarian cancer ...

Allarity Therapeutics, Inc. (NASDAQ:ALLR) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted Fast ...

Initial ultrasounds suggested an ectopic pregnancy, which is a life-threatening condition where a fertilized egg implants ...

Get regular checkups and listen to your body. It’s part of a conversation Bates had with People about her experience with ...

In a rare and high-risk surgery, a 25-year-old pregnant woman from Bhiwadi successfully delivered a healthy baby boy after ...

Emerging treatments for low-grade serous ovarian cancer and platinum-resistant disease offer new hope, with promising data ...

A study compares second-look laparoscopy and circulating tumor DNA (ctDNA) to detect residual ovarian cancer and predict ...

A pregnant woman safely gave birth after a rare surgery to remove a basketball-sized ovarian tumor. Detected at 14 weeks, ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway ...

A 25-year-old woman from Bhiwadi safely delivered a baby after undergoing surgery to remove a substantial ovarian tumor ...

Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook—surgery ...

Experiments revealed that the cancer cells of inflamed tumors respond to a standard combination of chemotherapy and olaparib—a drug used to treat BRCA-deficient ovarian cancer—by activating a ...